ADC Therapeutics America, Inc.
$5.1M 4,269 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Jcbd, LLC
Jcbd, LLC reported $5,089,478.86 across General Payments, Research, and Ownership to 10 physicians and teaching hospitals across 12 transactions.
- $5.1M Top quartile payer
- All-tracks total
- 12 Below-median volume
- Transactions
- 10 Below-median reach
- Recipients
- #274
- of 1,925 companies
Jcbd, LLC reported $5,089,478.86 across all CMS Open Payments tracks (General + Research + Ownership) to 10 physicians and teaching hospitals in Program Year 2024 - ranking #274 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $65,300.00, averaging $508.9K per recipient.
How Jcbd, LLC's $5.1M all-tracks total breaks down
Jcbd, LLC's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
22/100
Total payments
D
57/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
10/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer jcbd-llc Jcbd, LLC
$5.1M · #274/1,925 · 0.0% industry · PY2024
- TOT $5.1M
- RANK #274
- SHARE 0.0%
- TXN 12
- RCP 10
- CAT 1
- GEN $65.3K
- TOP1 100.0%
- PY 2024
Volume peers
Nearest volume peer: ADC Therapeutics America, Inc. ($5.1M)
Jcbd, LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Jcbd, LLC
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Jcbd, LLC, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
"Acquisitions" leads the 1-category general-payment breakdown below at $65.3K (100.0% of General Payments, 10 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
Across 1 types of general payments, Jcbd, LLC's largest category was "Acquisitions" at $65.3K - 100.0% of General Payments.
How Jcbd, LLC divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Acquisitions | $65.3K | 10 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $65,300.00 (100.0%) of $65,300.00 in this company's General Payments records across 1 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Jcbd, LLC
The five named recipients with the highest reported General Payments from this company
- 1
Edward Jeffrey Donner
$65,300.00 across 10 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Jcbd, LLC's spend rank (#274 of 1,925, top 14% by spend) and concentration rank (#130 of 1,838, top 7% most concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- FKG Dentaire Sarl : $56.8K total payments, HHI 10000
- Gyder Surgical US Inc : $29.2K total payments, HHI 10000
- Fluxergy, Inc. : $10.2K total payments, HHI 10000
- Anser Implants Holding BV : $15.5K total payments, HHI 10000
- Midwest Medical Resources Inc : $1.0K total payments, HHI 10000
- Genesis Innovation Group, Inc. : $136.00 total payments, HHI 10000
- Jcbd, LLC (this company) : $65.3K total payments, HHI 10000
- Diagnostic Green GmbH : $36.0K total payments, HHI 10000
- Pixee Medical Inc. : $601.00 total payments, HHI 10000
- InSightec,LTD : $865.8K total payments, HHI 9998
- Edge Endo LLC : $91.1M total payments, HHI 9988
- Ikon Spine LLC : $120.5K total payments, HHI 9985
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Jcbd, LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Jcbd, LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Jcbd, LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
BrainScope Company, Inc.
$5.1M 25 recipients
Compare payment profiles
American Medical Technology Inc
$5.1M 0 recipients
Compare payment profiles
Spineart SA
$5.1M 233 recipients
Compare payment profiles
Pristine Surgical LLC
$5.1M 5 recipients
Compare payment profiles
SK Life Science, Inc.
$5.1M 20,538 recipients
Compare payment profiles
Put this to use
Jcbd, LLC ranks #274 of 1,925 by all-tracks total payments, led by "Acquisitions".
- See where Jcbd, LLC sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Acquisitions" spend across every manufacturer, not just Jcbd, LLC. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.